• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤相关淀粉样变性患者发生慢性肝衰竭急性发作的罕见病例。

Rare case of acute on chronic hepatic failure in a patient with multiple myeloma-associated amyloidosis.

作者信息

Muhammad Khan Muzammil, Ur Rashid Mamoon, Ullah Waqas, Hussain Ishtiaq, Hurairah Abu

机构信息

Internal Medicine, Khyber Medical College, Peshawar, Pakistan.

Internal Medicine, AdventHealth Dade City, Dade City, Florida, USA.

出版信息

BMJ Case Rep. 2020 Jan 28;13(1):e231563. doi: 10.1136/bcr-2019-231563.

DOI:10.1136/bcr-2019-231563
PMID:31996385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7021185/
Abstract

Amyloidosis is the extracellular deposition of unique protein fibrils in different tissue organs. It is most commonly associated with B-cell malignancy such as multiple myeloma or Waldenstrom macroglobulinaemia. It involves the liver, heart, kidney, peripheral nerves and soft tissues. Liver however is affected, but clinically apparent disease is very rare. Hepatomegaly and mild elevation of alkaline phosphatase is the most common presentation in patients with liver involvement. Acute hepatic failure is a rare presentation with myeloma-induced amyloidosis. The diagnosis can be difficult requiring biopsy or sometimes special staining of the tissue. Management is still very challenging.

摘要

淀粉样变性是独特的蛋白质原纤维在不同组织器官中的细胞外沉积。它最常与B细胞恶性肿瘤相关,如多发性骨髓瘤或华氏巨球蛋白血症。它累及肝脏、心脏、肾脏、周围神经和软组织。肝脏虽会受到影响,但临床上明显的疾病非常罕见。肝肿大和碱性磷酸酶轻度升高是肝脏受累患者最常见的表现。急性肝衰竭是骨髓瘤诱导的淀粉样变性的罕见表现。诊断可能困难,需要进行活检,有时还需要对组织进行特殊染色。治疗仍然非常具有挑战性。

相似文献

1
Rare case of acute on chronic hepatic failure in a patient with multiple myeloma-associated amyloidosis.多发性骨髓瘤相关淀粉样变性患者发生慢性肝衰竭急性发作的罕见病例。
BMJ Case Rep. 2020 Jan 28;13(1):e231563. doi: 10.1136/bcr-2019-231563.
2
Myeloma associated amyloidosis presenting as subacute liver failure.以亚急性肝衰竭为表现的骨髓瘤相关性淀粉样变性
Postgrad Med J. 2006 Jul;82(969):e13. doi: 10.1136/pgmj.2006.044883.
3
Multiple Myeloma Associated Intestinal Amyloidosis: Intestinal Pseudoobstruction Falsely Considered as an Ascites.多发性骨髓瘤相关性肠淀粉样变性:被误诊为腹水的肠假性梗阻
Rev Recent Clin Trials. 2018 Jan 31;13(1):79-81. doi: 10.2174/0929867324666170830114914.
4
Acute liver failure due to primary amyloidosis in a nephrotic syndrome: a swiftly progressive course.肾病综合征中由原发性淀粉样变性引起的急性肝衰竭:病情迅速进展。
BMJ Case Rep. 2016 Mar 10;2016:bcr2016214392. doi: 10.1136/bcr-2016-214392.
5
Rapidly progressive glomerulonephritis complicating primary AL amyloidosis and multiple myeloma.原发性 AL 淀粉样变性合并多发性骨髓瘤并发快速进行性肾小球肾炎。
Nephrol Dial Transplant. 2010 Aug;25(8):2786-9. doi: 10.1093/ndt/gfp715. Epub 2009 Dec 29.
6
Multiple myeloma-associated amyloidosis manifesting as fulminant hepatic failure.表现为暴发性肝衰竭的多发性骨髓瘤相关性淀粉样变性
South Med J. 2001 Oct;94(10):1036-8.
7
Hepatic failure due to myeloma-associated amyloidosis.
J Gastroenterol. 1998 Dec;33(6):926-7. doi: 10.1007/s005350050206.
8
Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.体外膜肺氧合作为系统性轻链淀粉样变性所致急性心力衰竭的决策桥梁。
Am J Case Rep. 2015 Mar 24;16:174-81. doi: 10.12659/AJCR.892772.
9
Multiple Myeloma Light Chain Amyloidosis Presenting as Hepatic Failure.
S D Med. 2018 Mar;71(3):112-115.
10
[Acute Liver Failure in patient with liver amyloidosis associated to multiple myeloma].
Rev Med Chil. 2003 Nov;131(11):1301-4.

引用本文的文献

1
miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.miRNAs 与多发性骨髓瘤:关注发病机制、预后和耐药性。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231202391. doi: 10.1177/15330338231202391.

本文引用的文献

1
Primary Hepatic Amyloidosis Presenting as Acute-on-Chronic Liver Failure.表现为慢加急性肝衰竭的原发性肝淀粉样变性
ACG Case Rep J. 2017 Feb 15;4:e22. doi: 10.14309/crj.2017.22. eCollection 2017.
2
Primarily isolated hepatic involvement of amyloidosis: A case report and overview.原发性孤立性肝脏淀粉样变性:一例报告及概述
Medicine (Baltimore). 2016 Dec;95(52):e5645. doi: 10.1097/MD.0000000000005645.
3
Poor Outcomes in Hepatic Amyloidosis: A Report of 2 Cases.肝淀粉样变性的不良预后:2例报告
Case Rep Oncol Med. 2016;2016:7625940. doi: 10.1155/2016/7625940. Epub 2016 Sep 28.
4
Disease-free survival following high dose or standard dose therapy in patients with amyloidosis.淀粉样变性患者接受高剂量或标准剂量治疗后的无病生存期。
Br J Haematol. 2016 Jul;174(1):153-5. doi: 10.1111/bjh.13656. Epub 2015 Aug 28.
5
The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis.超声心动图在心脏淀粉样变性无创诊断中的作用。
J Echocardiogr. 2015 Sep;13(3):84-9. doi: 10.1007/s12574-015-0249-1. Epub 2015 Jul 14.
6
Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient.在一名肝移植患者中使用硼替佐米和地塞米松治疗肝轻链淀粉样变
Hepatol Res. 2015 Oct;45(10):E150-5. doi: 10.1111/hepr.12462. Epub 2015 Jan 22.
7
Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis.环磷酰胺-硼替佐米-地塞米松(CyBorD)可使 AL 淀粉样变性患者迅速获得完全血液学缓解。
Blood. 2012 May 10;119(19):4391-4. doi: 10.1182/blood-2011-11-390930. Epub 2012 Feb 13.
8
Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival.环磷酰胺、硼替佐米和地塞米松治疗 AL 淀粉样变性与高克隆反应率和延长无进展生存期相关。
Blood. 2012 May 10;119(19):4387-90. doi: 10.1182/blood-2011-10-388462. Epub 2012 Feb 13.
9
κ I light chain AL amyloidosis presenting with rapidly progressive renal and hepatic failure with unusual renal amyloid distribution.
Clin Nephrol. 2012 Jan;77(1):66-70. doi: 10.5414/cn106804.
10
Fatal Subacute Hepatic Failure in a Patient with AA-Type Amyloidosis: Case Report.1例AA型淀粉样变性患者发生致命性亚急性肝衰竭:病例报告
Patholog Res Int. 2010 May 16;2010:648089. doi: 10.4061/2010/648089.